Press Releases

Company Announcement No. 1112

DSV A/S hereby provides notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in DSV A/S made by a manager.

Any questions may be addressed to Investor Relations, Sebastian Rosborg, tel. +45 43 20 33 87.

Yours sincerely,DSV A/S

Attachment

• 1112 - Announcement (24.05.2024) - MANAGER’S TRANSACTIONS IN DSV AS SHARES

Partnership Enhances Compliance and Efficiency, Empowering Nonprofits to Raise Millions Through Golf Fundraisers

SAN FRANCISCO, May 24, 2024 /PRNewswire/ -- Member for a Day, the leading golf nonprofit fundraising platform, announces today that it is partnering with Change, a donation processing and compliance platform, to revolutionize charitable golf auctions and sweepstakes. Golfers are able to bid on exclusive experiences to benefit a chosen charity on Member for... (continue reading...)

PITTSBURGH, May 24, 2024 /PRNewswire/ -- "I wanted to create a mirror that would provide positive daily affirmations to increase self-confidence," said an inventor, from Hampton, Ga., "so I invented THE I A M. My design helps you make positive changes, and it offers an alternative to writing affirmations on sticky notes and placing them on walls or mirrors."

... (continue reading...)

• PaxMedica has received an urgent plea from the Ministry of Health of Malawi for emergency access to IV suramin to prevent a potential humanitarian crisis due to dwindling supplies of essential drugs used to save lives in the region
• PaxMedica has previously concluded a Type B meeting with the FDA in preparation for the NDA submission, focusing on the use of PAX-101 in treating the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, transmitted by... (continue reading...)

• Clene recently participated in the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference
• CNM-Au8(R) is oral suspension developed to restore neuronal health and function by increasing energy production and utilization
• The therapy has been involved in clinical trials and compassionate use programs, accumulating over 600 years of exposure across various neurodegenerative conditions,... (continue reading...)